Ovarian cancer is relatively uncommon, and therefore little has been published to date regarding racial or ethnic variations in the incidence or mortality of this malignancy. As the U.S. population becomes more diverse, the interest in health problems and disparities in outcomes among minority and economically disadvantaged groups will continue to increase. In this supplement, the authors focus on epidemiology, pathology and classification issues, multiple primary tumors, staging, and incidence and mortality for race/ethnic groups. The authors also focused on epidemiologic differences between borderline tumors of low malignant potential and carcinomas.
No takes yet. Share an insight, caveat, or question.
Goodman et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: